BUDESONIDE/ FORMOTEROL FUMARATE DIHYDRATE INHALER (GoResp Digihaler®)
Clinical Indication
Comments
Discontinued June 2024 – see MHRA alert
Date of classification
March 2024
Do not prescribe
Drugs not recommended for use in LLR because of lack of evidence of clinical effectiveness, cost prioritization or concerns over safety.